Company Description
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data.
The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease.
BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
| Country | United States |
| IPO Date | Jan 20, 2023 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Vininder Singh |
Contact Details
Address: 325 Ellington Blvd. Gaithersburg, Maryland United States | |
| Website | https://www.bullfrogai.com |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | |
| ISIN Number | US12021E1174 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Vininder Singh | Founder, Chairman & Chief Executive Officer |
| Dane R. Saglio | Chief Financial Officer |
| J. T. Koffenberger | Chief Information Officer |
| Dr. David P. Recker FACP, FACR, M.D. | Chief Medical Officer |
| William Hirschman | Chief Commercial Officer |